Learn more about the need for closer collaboration between psychiatry and cannabis research to explore its therapeutic potential, mitigate risks, and advance evidence-based mental health treatments.
Mark W. Viner, MD
Advertisement
Dr Viner is a practicing physician who has been working with psychiatric patients in the state of Nevada for over 25 years. He served as a clinical professor of psychiatry and behavioral sciences at the University of Nevada School of Medicine.
Articles by Mark W. Viner, MD
Cannabis use disorder and schizophrenia both peak in prevalence around the same age. Is there a cause-and-effect relationship?
Mark Viner, MD, shares his thoughts on the place cannabis holds in psychiatry and addressing the stigma cannabis faces.
As cannabis transitions from an illicit drug to a multi-billion-dollar industry, psychiatry faces both challenges and opportunities in exploring its therapeutic potential while balancing the risks.
Advertisement
Latest Updated Articles
Exploring the Crossroads of Cannabis and PsychiatryPublished: February 17th 2025 | Updated:
How Cannabis Interacts With Psychedelics and the MemoryPublished: February 24th 2025 | Updated:
The Stigma on Cannabis in PsychiatryPublished: February 19th 2025 | Updated:
What is the Link Between Cannabis and Psychiatric Diagnoses?Published: February 21st 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Preliminary Report on Dangers of AI Chatbots
2
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
